The recommendation of two professional societies1 is putting Roche’s cobas® HPV Test back in the spotlight

Roche’s cobas HPV Test back in the spotlightThe debate among healthcare professionals about the best way to screen women for cervical cancer continues to draw praise from advocates of Roche’s cobas HPV Test as a first-line screening tool, even as those reluctant to adopt it believe it may lead to unnecessary follow-up exams and higher medical costs if Pap testing is replaced.

To read more, check out this recent article from the Indianapolis Star.

To learn more about the cobas HPV Test, visit our Women’s Health Forum.

1 Society of Gynecologic Oncology & American Society for Colposcopy and Cervical Pathology (Interim Clinical Guidance 2015).